| Title |
Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy
|
|---|---|
| Published in |
Applied Health Economics and Health Policy, March 2014
|
| DOI | 10.1007/s40258-014-0089-6 |
| Pubmed ID | |
| Authors |
Linda E. Green, Tuan A. Dinh, David A. Hinds, Bryan L. Walser, Richard Allman |
| Abstract |
Tamoxifen therapy reduces the risk of breast cancer but increases the risk of serious adverse events including endometrial cancer and thromboembolic events. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 13% |
| United Kingdom | 1 | 13% |
| United States | 1 | 13% |
| France | 1 | 13% |
| Saudi Arabia | 1 | 13% |
| Unknown | 3 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 3 | 38% |
| Members of the public | 3 | 38% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Colombia | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 63 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 24% |
| Student > Master | 11 | 17% |
| Other | 6 | 9% |
| Student > Bachelor | 5 | 8% |
| Student > Ph. D. Student | 3 | 5% |
| Other | 11 | 17% |
| Unknown | 14 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 38% |
| Economics, Econometrics and Finance | 6 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 8% |
| Psychology | 4 | 6% |
| Agricultural and Biological Sciences | 3 | 5% |
| Other | 7 | 11% |
| Unknown | 16 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2017.
All research outputs
#4,138,385
of 22,747,498 outputs
Outputs from Applied Health Economics and Health Policy
#183
of 771 outputs
Outputs of similar age
#41,520
of 221,294 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#5
of 20 outputs
Altmetric has tracked 22,747,498 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 771 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.